Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenz...
Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Abstract Background When an outbreak of a novel pathogen occurs, some of the most pressing questions...
[[abstract]]Background: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not we...
Estimating the age-specific incidence of an emerging pathogen is essential for understanding its sev...
During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were neede...
Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
BACKGROUND: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
OBJECTIVES: The objectives of the H1N1 2009 serological surveillance project were twofold: to docume...
Background: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
Seroprevalence survey is the most practical method for accurately estimating infection attack rate (...
BACKGROUND: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not well understoo...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
BACKGROUND: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not well understoo...
Background: During the 2009 pandemic of influenza A (H1N1), many studies reported estimates of the r...
Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Abstract Background When an outbreak of a novel pathogen occurs, some of the most pressing questions...
[[abstract]]Background: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not we...
Estimating the age-specific incidence of an emerging pathogen is essential for understanding its sev...
During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were neede...
Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
BACKGROUND: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
OBJECTIVES: The objectives of the H1N1 2009 serological surveillance project were twofold: to docume...
Background: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
Seroprevalence survey is the most practical method for accurately estimating infection attack rate (...
BACKGROUND: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not well understoo...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
BACKGROUND: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not well understoo...
Background: During the 2009 pandemic of influenza A (H1N1), many studies reported estimates of the r...
Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Abstract Background When an outbreak of a novel pathogen occurs, some of the most pressing questions...
[[abstract]]Background: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not we...